Boston Scientific, a major US medical technology company, suffered a cyberattack on August 25 that disrupted global operations, including the ability to process and ship customer orders. The company has disclosed the incident in an SEC filing but cannot yet determine the full scope of operational and financial impacts. It remains unclear whether a data breach occurred or which threat actor is responsible.
